MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjopen-2024-088998

Медицинская библиотека · BMJ open · 2025

Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from Generator Heart Failure DataMart.

Laborante Renzo, Delvinioti Agni, Tudor Andrada Mihaela, Lenkowicz Jacopo, Iacomini Chiara, Iaconelli Antonio, Paglianiti Donato Antonio, Galli Mattia, Rodolico Daniele, Patarnello Stefano, Restivo Attilio, Ciliberti Giuseppe, Rizzo Gaetano, Bianchini Emiliano, Busti Matteo, Sensini Luca, Valentini Vincenzo, Scambia Giovanni, Gasbarrini Antonio, Crea Filippo, Cesario Alfredo, Savarese Gianluigi, Patti Giuseppe, D'Amario Domenico

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the trend of prescription of the four foundational therapies, and their impact on 30-day urgent re-admissions and all-cause death in patients with heart failure and reduced ejection fraction (HFrEF) following an acute decompensation event.

DESIGN

Retrospective.

SETTING

One tertiary referral centre.

PARTICIPANTS

999 consecutively patients admitted with a primary diagnosis of HFrEF between January 2020 and June 2023 were identified through a validated, high-performance technology infrastructure based on artificial intelligence. The entire cohort was divided into three time periods based on two time points: September 2021 (ie, the release of the latest European guidelines) and January 2022 (ie, reimbursement for sodium-glucose cotransporter 2 (SGLT2) inhibitors).

PRIMARY AND SECONDARY OUTCOME MEASURES: Trends and predictors of the prescription of each of the four foundational therapies and of the composite of all-cause death and rehospitalisation for urgent causes at 30 days.

RESULTS

Among the 999 included patients, β-blockers were prescribed in 93% of patients, ACE inhibitor (ACEi)/angiotensin receptor blocker (ARB)/angiotensin-neprilysin receptor inhibitor (ARNi) in 73%, mineralocorticoid receptor antagonist in 30% and SGLT2 inhibitors in 18%. Over time, an increase in the prescription rate occurred only for SGLT2 inhibitors (3% vs 10% vs 32%, p<0.001), whereas the rate of the composite of all-cause death and rehospitalisation for urgent causes at 30 days remained stable (9.9% vs 10.3% vs 8.4%; p=ns). In multivariate analysis, the use of ACEi/ARB/ARNi was associated with a lower risk of 30-day all-cause death and urgent rehospitalisation (adjusted OR 0.38; 95% CI 0.24 to 0.59; p<0.01). Conversely, the prescription of furosemide at discharge (adjusted OR 2.25; 95% CI 95% 1.29 to 3.94; p<0.01) and a previous genitourinary infection (adjusted OR 4.02; 95% CI 1.67 to 9.68; p<0.01) were associated with higher risk of 30-day all-cause death and urgent rehospitalisation.

CONCLUSIONS

In our study, early adoption of guideline-recommended medical therapy is still limited, with a significant rise in SGLT2i prescriptions after January 2022 and a lower risk of the composite of all-cause death and urgent readmissions at 30 days restricted to the use of ACEi/ARB/ARNi.

Для цитирования: Laborante Renzo, Delvinioti Agni, Tudor Andrada Mihaela, Lenkowicz Jacopo, Iacomini Chiara, Iaconelli Antonio, Paglianiti Donato Antonio, Galli Mattia, Rodolico Daniele, Patarnello Stefano, Restivo Attilio, Ciliberti Giuseppe, Rizzo Gaetano, Bianchini Emiliano, Busti Matteo, Sensini Luca, Valentini Vincenzo, Scambia Giovanni, Gasbarrini Antonio, Crea Filippo, Cesario Alfredo, Savarese Gianluigi, Patti Giuseppe, D'Amario Domenico. Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from Generator Heart Failure DataMart.. BMJ open. 2025. DOI: 10.1136/bmjopen-2024-088998.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.